In Vitro Activity of New β-Lactamase Inhibitor Combinations against <i>bla</i>_NDM, <i>bla</i>_KPC, and ESBL-Producing Enterobacteriales Uropathogens

• Asıl Yazarlar: Lubna Razaq (Yazar), Fakhur Uddin (Yazar), Shahzad Ali (Yazar), Shah Muhammad Abbasi (Yazar), Muhammad Sohail (Yazar), Nabila E. Yousif (Yazar), Hala M. Abo-Dief (Yazar), Zeinhom M. El-Bahy (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2023-09-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Antibiotic resistance in uropathogens has increased substantially and severely affected treatment of urinary tract infections (UTIs). Lately, some new formulations, including meropenem/vaborbactam (MEV), ceftazidime/avibactam (CZA), and ceftolozane/tazobactam (C/T) have been introduced to treat infe...